Supplements

Does melatonin actually help you sleep, and is a lower dose better?

By SoS Staff 7 August 2026 5 min read

Evidence

Well established

Read

5 min read

Filed under

Supplements

TL;DR

Melatonin does help with sleep, but the effect is smaller than most people expect and works mainly by shifting your circadian timing rather than sedating you. A well-known meta-analysis by Ferracioli-Oda et al. (2013, PLOS ONE, pooling 19 RCTs) found melatonin reduced time to fall asleep by about 7 minutes and increased total sleep time by about 8 minutes compared to placebo. Lower doses — in the 0.3–1mg range — appear to work about as well as the 3–10mg doses common in supplements, and they cause less next-day grogginess and less disruption of the body's own melatonin rhythm. If you're using it for jet lag or delayed sleep phase, the timing of the dose matters more than the size of it.

How does melatonin actually work in the body?

Your pineal gland releases melatonin in the evening as light fades, and it's one of the main signals your brain uses to know what time it is — not a sedative in the way a benzodiazepine or antihistamine is. That's an important distinction, because it explains why melatonin's effect on sleep is more about nudging your circadian clock than about knocking you unconscious.

The receptors it binds to, MT1 and MT2 in the suprachiasmatic nucleus, are involved in "phase-shifting" — telling your body it's time to wind toward sleep. This is why melatonin tends to work best for circadian misalignment problems: jet lag, shift work, delayed sleep phase disorder in teens and young adults. It's less impressive for garden-variety insomnia where the problem isn't timing but arousal or anxiety keeping you up.

What does the research actually show?

The most-cited synthesis here is Ferracioli-Oda, Qawasmi, and Bloch's 2013 meta-analysis in PLOS ONE, which pooled 19 randomized controlled trials. The topline numbers: sleep latency dropped by about 7 minutes and total sleep time rose by about 8 minutes versus placebo. Sleep quality scores improved too, but the effect size was modest (a standardized mean difference around 0.3, which is a small-to-moderate effect in statistical terms).

That's real, but it's not the "you'll be out cold in 20 minutes" story melatonin gets marketed as. For comparison, prescription sleep aids in trials often show latency reductions of 20+ minutes. Melatonin's real strength shows up in circadian-mistimed sleep — a 2002 Cochrane review by Herxheimer and Petrie on jet lag found melatonin taken close to the target bedtime at the destination significantly reduced jet lag symptoms across multiple trials, with doses from 0.5mg to 5mg performing similarly.

That last point is the crux of the dosing question: bigger doses didn't reliably outperform smaller ones in that review. This lines up with pharmacology — a 2005 study in the Journal of Clinical Endocrinology & Metabolism by Zhdanova and colleagues found that a 0.3mg dose was enough to produce blood melatonin levels within the normal physiological range, while a 3.0mg dose pushed levels to roughly 10 times higher than what your body naturally produces at night. Higher blood concentrations didn't translate into proportionally better sleep in that work — they mostly just meant a longer tail of melatonin lingering in your system into the next morning.

Is a lower dose actually better, or just less risky?

Both, probably. The evidence points to lower doses (0.3–1mg) achieving sleep-onset benefits comparable to higher commercial doses (3–10mg), while producing less residual next-day sedation and less disruption to your endogenous melatonin production. There's also a receptor-desensitization concern: chronically flooding MT1/MT2 receptors with supraphysiological doses could, in theory, blunt their responsiveness over time, though the long-term human trial data on this specific question is thin — most trials run weeks, not years.

The commercial dosing (3mg, 5mg, 10mg) isn't really evidence-based; it's more a legacy of what was easy to formulate and market, especially once melatonin was regulated as a supplement in the U.S. rather than a drug requiring dose-response trials. If you're experimenting, most sleep researchers who study this — including Richard Wurtman, whose lab did some of the original human melatonin pharmacokinetics work — have argued for starting low.

Are there risks or limitations worth knowing about?

Melatonin is generally well tolerated in short-term use — grogginess, headache, and mild dizziness are the most common complaints. Longer-term safety data, especially at high doses over months or years, is genuinely limited; most RCTs run 4–12 weeks. There's also a real quality-control problem: a 2017 study in the Journal of Clinical Sleep Medicine by Erland and Turner tested 31 melatonin supplements and found actual content ranged from 83% less to 478% more than the labeled dose, and some products contained serotonin as an undisclosed contaminant. So even if you pick a "low dose" product, what's in the bottle may not match the label.

Melatonin can also interact with blood thinners, immunosuppressants, and diabetes medications, and it's not well studied in pregnancy. It's worth flagging to a doctor if you're on other medications, taking it regularly, or considering it for a child.

FAQ

Q: What's the best dose to start with?
A: Trial evidence, including Zhdanova's dose-response work, suggests 0.3–1mg is often enough to help with sleep timing, and going higher (3–10mg) doesn't reliably improve outcomes — it mostly extends how long melatonin stays in your system. Many sleep clinicians suggest starting at the low end and adjusting only if needed.

Q: When should I take it?
A: Timing relative to your target sleep or destination time zone matters more than dose, especially for jet lag. For everyday sleep-onset issues, most trials dose it 30–60 minutes before intended bedtime.

Q: Is melatonin habit-forming?
A: There's no strong evidence of physical dependence the way there is with benzodiazepines, but the receptor-desensitization question with chronic high-dose use isn't fully settled, and long-duration human data is sparse.

Q: Does melatonin help with anxiety-driven insomnia?
A: Not much, based on the mechanism. Melatonin addresses circadian timing, not the arousal or racing-thoughts type of insomnia. If that's your issue, the modest effect sizes in the Ferracioli-Oda meta-analysis are a reasonable expectation to set.

Q: Should kids take melatonin?
A: This is an area with much less trial data and real supply quality-control concerns (per the Erland and Turner analysis). It's worth talking to a pediatrician rather than reaching for an adult gummy dose.

Sources

Medical Disclaimer

This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions or using any treatments discussed herein, including melatonin, especially if you take other medications or are considering giving it to a child. Results vary by individual.